ATE201881T1 - Monoklonare antikörper, spezifisch für dcc- genprodukt - Google Patents

Monoklonare antikörper, spezifisch für dcc- genprodukt

Info

Publication number
ATE201881T1
ATE201881T1 AT93110213T AT93110213T ATE201881T1 AT E201881 T1 ATE201881 T1 AT E201881T1 AT 93110213 T AT93110213 T AT 93110213T AT 93110213 T AT93110213 T AT 93110213T AT E201881 T1 ATE201881 T1 AT E201881T1
Authority
AT
Austria
Prior art keywords
dcc
dcc gene
gene product
antibodies specific
monoclonal antibodies
Prior art date
Application number
AT93110213T
Other languages
English (en)
Inventor
Nobuo Hanai
Shozo Baba
Tadachika Ozawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Application granted granted Critical
Publication of ATE201881T1 publication Critical patent/ATE201881T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT93110213T 1992-06-25 1993-06-25 Monoklonare antikörper, spezifisch für dcc- genprodukt ATE201881T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16710192A JP3151054B2 (ja) 1992-06-25 1992-06-25 抗ｄｃｃ遺伝子産物モノクローナル抗体

Publications (1)

Publication Number Publication Date
ATE201881T1 true ATE201881T1 (de) 2001-06-15

Family

ID=15843450

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93110213T ATE201881T1 (de) 1992-06-25 1993-06-25 Monoklonare antikörper, spezifisch für dcc- genprodukt

Country Status (7)

Country Link
US (1) US5445938A (de)
EP (1) EP0577028B1 (de)
JP (1) JP3151054B2 (de)
AT (1) ATE201881T1 (de)
AU (1) AU675067B2 (de)
CA (1) CA2099628A1 (de)
DE (1) DE69330297T2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2115611T3 (es) * 1990-01-04 1998-07-01 Univ Johns Hopkins Gen suprimido en el cancer colorrectal humano.
WO1994028161A1 (en) * 1993-05-26 1994-12-08 The Johns Hopkins University Antibodies specific for dcc gene product
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US7935675B1 (en) * 1994-07-15 2011-05-03 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6818787B2 (en) * 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
JPH03505675A (ja) * 1988-10-31 1991-12-12 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 新生表現型の抑制を制御する産生体及び方法
AU656716B2 (en) * 1989-09-15 1995-02-16 Genetic Systems Corporation Hybridoma CT43 producing a monoclonal antibody to a mucin epitope of colorectal cancer
ES2115611T3 (es) * 1990-01-04 1998-07-01 Univ Johns Hopkins Gen suprimido en el cancer colorrectal humano.

Also Published As

Publication number Publication date
DE69330297T2 (de) 2002-05-02
EP0577028A2 (de) 1994-01-05
CA2099628A1 (en) 1993-12-26
JPH067192A (ja) 1994-01-18
DE69330297D1 (de) 2001-07-12
JP3151054B2 (ja) 2001-04-03
AU4152193A (en) 1994-01-06
EP0577028A3 (de) 1994-11-02
AU675067B2 (en) 1997-01-23
EP0577028B1 (de) 2001-06-06
US5445938A (en) 1995-08-29

Similar Documents

Publication Publication Date Title
US5436154A (en) Monoclonal antibodies against human Tumor Necrosis Factor α
CN101970497B (zh) 抗‑EpCAM抗体及其用途
DE69119211D1 (de) Cdr-gepfropfte anti-cea-antikörper und ihre herstellung
MY137078A (en) Recombinant antibodies associated to gangliosides. their use indiagnosis and treatment of tumors.
MX9504802A (es) Anticuerpos anti-egfr y fvs de cadena simple anti-egfr.
EP4261223A1 (de) Anti-sirp? antikörper und anwendung davon
GB9120467D0 (en) Anti-hmfg antibodies and process for their production
RU97100179A (ru) Моноклональное антитело против cd44v6
FI981799L (fi) DNA-molekyylejä, jotka koodaavat CD25 sitovia molekyylejä
DE69129989D1 (de) Arzneimittelzusammensetzung zur behandlung oder vorbeugung maligner tumore
IE890018L (en) Novel antibodies
CA2149120A1 (en) Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof
DE69029808D1 (de) Monoklonale antikörper
EP0784684B8 (de) Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden
ATE201881T1 (de) Monoklonare antikörper, spezifisch für dcc- genprodukt
KR900015756A (ko) 모노크로날 항체
ATE58172T1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
AU6634596A (en) Monoclonal antibodies against soluble tnf-alpha receptors p55 and p75 as well as against tnf-alpha and its analogues
NO179328C (no) Antistoffer mot retinoblastom-genprodukt, anvedelse derav samt murint hybridom
KR930019820A (ko) 모노클로날 항-강글리오사이드 항체, 이의 제조방법 및 종양 치료제로서의 용도
Hashizume et al. Serodiagnosis of cancer, using porcine antigens recognized by human monoclonal antibody, HB4C5
CS276204B6 (sk) Myší hybridóm IFNA1-118 produkujúci minoklonálnu protilátku viažúcu íudský interferon alfa 1
SE9500148D0 (sv) Antibodies for use in cancer therapy and diagnosis
SE9501302D0 (sv) Antibodies for use in cancertherapy and diagnosis
CS276203B6 (sk) Myší hybridóm IFNA2-N10 produkujúci monoklonálnu protilátku viažúcu ludský interferon alfa 2